Income Tax Expense (Benefit) of Bio Essence Corp from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bio Essence Corp quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
  • Bio Essence Corp Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $800, unchanged year-over-year.
  • Bio Essence Corp annual Income Tax Expense (Benefit) for 2024 was $800, a 50% decline from 2023.
  • Bio Essence Corp annual Income Tax Expense (Benefit) for 2023 was $1,600, a 36% decline from 2022.
  • Bio Essence Corp annual Income Tax Expense (Benefit) for 2022 was $2,500, a 24% decline from 2021.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Bio Essence Corp Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $800 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q2 2024 $800 -$800 -50% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q2 2023 $1,600 -$1,600 -50% 01 Apr 2023 30 Jun 2023 10-Q/A 27 Nov 2024 2024 Q2
Q2 2022 $3,200 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2021 $3,300 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q2 2020 $3,300 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2

Bio Essence Corp Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $800 -$800 -50% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $1,600 -$900 -36% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $2,500 -$800 -24% 01 Jan 2022 31 Dec 2022 10-K 15 Apr 2024 2023 FY
2021 $3,300 $0 0% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $3,300 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.